Visual assessment of early emphysema and interstitial abnormalities on CT is useful in lung cancer risk analysis

European Radiology

Volumn 26, Issue 2, 2016, Pages 487-494

  Wille, Mathilde M W ^a   Thomsen, Laura H ^b   Petersen, Jens ^c   de Bruijne, Marleen ^c,d   Dirksen, Asger ^a   Pedersen, Jesper H ^e   Shaker, Saher B ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e University of Copenhagen   (Denmark)

Author keywords

Comorbidity; Computed tomography; Emphysema; Interstitial abnormalities; Lung cancer

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; COMPUTED TOMOGRAPHY SCANNER; FEMALE; HUMAN; IMAGE ANALYSIS; LUNG CANCER; LUNG EMPHYSEMA; LUNG INTERSTITIUM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER DIAGNOSIS; LUNG; LUNG TUMOR; NETHERLANDS; OBSERVER VARIATION; ODDS RATIO; PREDICTIVE VALUE; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NETHERLANDS; OBSERVER VARIATION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PULMONARY EMPHYSEMA; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84954386943     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3826-9     Document Type: Article

References (32)

1. Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 5:395–409
2. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 5:277–300
3. Bach PB, Mirkin JN, Oliver TK et al (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 22:2418–29
4. Field JK, van Klaveren R, Pedersen JH et al (2013) European randomized lung cancer screening trials: Post NLST. J Surg Oncol 5:280–6
5. Humphrey LL, Deffebach M, Pappas M et al (2013) Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 6:411–20
6. Field JK, Oudkerk M, Pedersen JH, Duffy SW (2013) Prospects for population screening and diagnosis of lung cancer. Lancet 9893:732–41
7. McWilliams A, Tammemagi MC, Mayo JR et al (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 10:910–9
8. Tammemagi CM, Pinsky PF, Caporaso NE et al (2011) Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 13:1058–68
9. Spitz MR, Etzel CJ, Dong Q et al (2008) An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) 4:250–4
10. Bach PB, Kattan MW, Thornquist MD et al (2003) Variations in lung cancer risk among smokers. J Natl Cancer Inst 6:470–8
11. Tammemagi MC, Katki HA, Hocking WG et al (2013) Selection criteria for lung-cancer screening. N Engl J Med 8:728–36
12. Kovalchik SA, Tammemagi M, Berg CD et al (2013) Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 3:245–54
13. Mizuno S, Takiguchi Y, Fujikawa A et al (2009) Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer. Respirology 3:377–83
14. Gierada DS, Guniganti P, Newman BJ et al (2011) Quantitative CT assessment of emphysema and airways in relation to lung cancer risk. Radiology 3:950–9
15. Le Jeune I, Gribbin J, West J et al (2007) The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 12:2534–40
16. Hubbard R, Venn A, Lewis S, Britton J (2000) Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 1:5–8
17. Harris JM, Johnston ID, Rudd R, Taylor AJ, Cullinan P (2010) Cryptogenic fibrosing alveolitis and lung cancer: the BTS study. Thorax 1:70–6
18. Wells C, Mannino DM (1996) Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991. South Med J 5:505–10
19. Jin GY, Lynch D, Chawla A et al (2013) Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2:563–71
20. Pedersen JH, Ashraf H, Dirksen A et al (2009) The Danish randomized lung cancer CT screening trial–overall design and results of the prevalence round. J Thorac Oncol 5:608–14
21. Wille MMW, Thomsen LH, Dirksen A, et al. (2014) Emphysema progression is visually detectable in low-dose CT scans in continuous but not in former smokers. European Radiology
22. Ashraf H, Lo P, Shaker SB et al (2011) Short-term effect of changes in smoking behaviour on emphysema quantification by CT. Thorax 1:55–60
23. Dirksen A (2008) Monitoring the progress of emphysema by repeat computed tomography scans with focus on noise reduction. Proc Am Thorac Soc 9:925–8
24. de Torres JP, Bastarrika G, Wisnivesky JP et al (2007) Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 6:1932–8
25. Wilson DO, Weissfeld JL, Balkan A et al (2008) Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 7:738–44
26. Sverzellati N, Guerci L, Randi G et al (2011) Interstitial lung diseases in a lung cancer screening trial. Eur Respir J 2:392–400
27. Kwak N, Park CM, Lee J et al (2014) Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med 3:524–30
28. Camiciottoli G, Orlandi I, Bartolucci M et al (2007) Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 3:672–81
29. Xu Y, van Beek EJ, Hwanjo Y et al (2006) Computer-aided classification of interstitial lung diseases via MDCT: 3D adaptive multiple feature method (3D AMFM). Acad Radiol 8:969–78
30. Hartley PG, Galvin JR, Hunninghake GW et al (1985) (1994) High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease. J Appl Physiol 1:271–7
31. Shaker SB, Stavngaard T, Laursen LC, Stoel BC, Dirksen A (2011) Rapid fall in lung density following smoking cessation in COPD. COPD 1:2–7
32. Shaker SB, Dirksen A, Lo P et al (2012) Factors influencing the decline in lung density in a Danish lung cancer screening cohort. Eur Respir J 5:1142–8